Single-Site Study of Naltrexone/Acetaminophen for the Acute Treatment of Migraine: A Phase 2 Randomized Trial
Clinical trial NCT05685225 · WITHDRAWN
Trial details
- NCT number
- NCT05685225
- Sponsor
- Allodynic Therapeutics, Inc
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-31
- Primary completion
- 2025-12-02
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.